Grace Gilmore

548 total citations
22 papers, 376 citations indexed

About

Grace Gilmore is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Hematology. According to data from OpenAlex, Grace Gilmore has authored 22 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Grace Gilmore's work include Cannabis and Cannabinoid Research (4 papers), MicroRNA in disease regulation (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Grace Gilmore is often cited by papers focused on Cannabis and Cannabinoid Research (4 papers), MicroRNA in disease regulation (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). Grace Gilmore collaborates with scholars based in Australia, United States and Canada. Grace Gilmore's co-authors include Ross Baker, Jim Thom, Emmanuel J. Favaloro, Dylan M. Zylla, Soma Mohammed, John W. Eikelboom, Graeme J. Hankey, Qilong Yi, Sara Richter and Konrad Jamrozik and has published in prestigious journals such as Journal of Clinical Oncology, Stroke and Molecules.

In The Last Decade

Grace Gilmore

22 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grace Gilmore Australia 12 104 93 86 84 75 22 376
G.F. Gensini Italy 12 60 0.6× 129 1.4× 32 0.4× 77 0.9× 33 0.4× 35 331
Micha Milovanovic Sweden 11 51 0.5× 50 0.5× 43 0.5× 18 0.2× 21 0.3× 24 328
Marcello Sciaraffia Italy 10 29 0.3× 65 0.7× 33 0.4× 30 0.4× 32 0.4× 12 380
Necati Dağlı Türkiye 10 22 0.2× 153 1.6× 62 0.7× 121 1.4× 24 0.3× 24 426
Kensuke Takabayashi Japan 7 35 0.3× 260 2.8× 21 0.2× 29 0.3× 18 0.2× 26 588
Yi‐Heng Li Taiwan 15 50 0.5× 361 3.9× 16 0.2× 79 0.9× 13 0.2× 37 554
Sergi Torramadé‐Moix Spain 12 53 0.5× 70 0.8× 12 0.1× 33 0.4× 12 0.2× 20 388
Wojciech Romanowski Poland 13 35 0.3× 64 0.7× 73 0.8× 36 0.4× 17 0.2× 37 379
Manlio Prior Italy 13 9 0.1× 153 1.6× 57 0.7× 120 1.4× 22 0.3× 26 423

Countries citing papers authored by Grace Gilmore

Since Specialization
Citations

This map shows the geographic impact of Grace Gilmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Gilmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Gilmore more than expected).

Fields of papers citing papers by Grace Gilmore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace Gilmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Gilmore. The network helps show where Grace Gilmore may publish in the future.

Co-authorship network of co-authors of Grace Gilmore

This figure shows the co-authorship network connecting the top 25 collaborators of Grace Gilmore. A scholar is included among the top collaborators of Grace Gilmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace Gilmore. Grace Gilmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fogarty, Helen, et al.. (2023). PB0051 Persistent Elevation of ɣ’ Fibrinogen in Acute and Convalescent COVID-19. Research and Practice in Thrombosis and Haemostasis. 7. 100917–100917. 2 indexed citations
2.
Zylla, Dylan M., et al.. (2022). A novel cannabis education clinic for patients with cancer: Patient characteristics from initial visit.. Journal of Clinical Oncology. 40(28_suppl). 298–298. 1 indexed citations
3.
Elaskalani, Omar, et al.. (2022). Adenosine 2A Receptor Activation Amplifies Ibrutinib Antiplatelet Effect; Implications in Chronic Lymphocytic Leukemia. Cancers. 14(23). 5750–5750. 1 indexed citations
4.
Zylla, Dylan M., Grace Gilmore, Gabriela Vazquez‐Benitez, et al.. (2021). A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction. Supportive Care in Cancer. 29(12). 7471–7478. 38 indexed citations
5.
Gilmore, Grace, et al.. (2021). Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports. Cannabis and Cannabinoid Research. 7(1). 24–33. 25 indexed citations
6.
Adams, MJ, et al.. (2021). Estradiol-Responsive miR-365a-3p Interacts with Tissue Factor 3′UTR to Modulate Tissue Factor-Initiated Thrombin Generation. Thrombosis and Haemostasis. 121(11). 1483–1496. 5 indexed citations
7.
8.
Zylla, Dylan M., et al.. (2019). Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy. Journal of Diabetes and its Complications. 33(4). 335–339. 22 indexed citations
9.
Zylla, Dylan M., Grace Gilmore, Gabriela Vazquez‐Benitez, et al.. (2019). A randomized trial of medical cannabis (MC) in patients with advanced cancer (AC) to assess impact on opioid use and cancer-related symptoms.. Journal of Clinical Oncology. 37(31_suppl). 109–109. 2 indexed citations
10.
11.
Zylla, Dylan M., et al.. (2018). Incidence of diabetes and hyperglycemia among patients receiving glucocorticoids with chemotherapy.. Journal of Clinical Oncology. 36(30_suppl). 286–286. 1 indexed citations
12.
Tiao, J., et al.. (2017). Circulating MicroRNA as Thrombosis Sentinels: Caveats and Considerations. Seminars in Thrombosis and Hemostasis. 44(3). 206–215. 14 indexed citations
13.
Le, Bao T., et al.. (2017). Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties. Molecules. 22(10). 1770–1770. 28 indexed citations
14.
Williams, T. G., et al.. (2017). Measures of and changes in heart rate variability in pediatric heart transplant recipients. Pediatric Transplantation. 21(4). 3 indexed citations
15.
Adams, MJ, Jim Thom, Graeme J. Hankey, et al.. (2006). The tissue factor pathway in ischemic stroke. Blood Coagulation & Fibrinolysis. 17(7). 527–532. 13 indexed citations
16.
Blackwell, Nikki, et al.. (2005). Antistreptokinase antibodies: implications for thrombolysis in a region with endemic streptococcal infection: Table 1. Journal of Clinical Pathology. 58(9). 1005–1007. 6 indexed citations
17.
Eikelboom, John W., Graeme J. Hankey, Jim Thom, et al.. (2005). Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial. Journal of Thrombosis and Haemostasis. 3(12). 2649–2655. 41 indexed citations
18.
Thom, Jim, et al.. (2004). Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant. Blood Coagulation & Fibrinolysis. 15(4). 353–357. 4 indexed citations
19.
20.
Duncan, Elizabeth M., et al.. (2002). A Comparative Multi-laboratory Assessment of Three Factor VIII/von Willebrand Factor Concentrates. Thrombosis and Haemostasis. 87(3). 466–476. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G.F. Gensini Breakdown of academic impact, for papers by Micha Milovanovic Breakdown of academic impact, for papers by Marcello Sciaraffia Breakdown of academic impact, for papers by Necati Dağlı Breakdown of academic impact, for papers by Kensuke Takabayashi Breakdown of academic impact, for papers by Yi‐Heng Li Breakdown of academic impact, for papers by Sergi Torramadé‐Moix Breakdown of academic impact, for papers by Wojciech Romanowski Breakdown of academic impact, for papers by Manlio Prior
Rankless by CCL
2026